India's Laurus Labs closes up after USFDA report for Visakhapatnam facility
** Shares of Laurus Labs LAUL.NS close up 2.16% at 366.75
rupees, their highest closing level since Jan. 11
** Co receives Establishment Inspection Report From USFDA
after inspection at Visakhapatnam facility
** Around 3.42 mln shares traded by close of trade, 1.3x the
30-day avg
** Avg rating of 11 brokerages around equivalent of "hold"
with median PT of 315.00 rupees - Refinitiv data
** Stock cuts YTD loss to 2.27% from 4.33% at last close
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs hits record high as Q2 profit more than doubles
Brief: Laurus Labs Declares Dividend Of 1 Rupee Per Share
Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
Brief: Laurus Labs Invests 120.96 Million Rupees In Kurnool Renewables Via Rights Issue
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig